Latest news

Filters
November 8, 2019

Debiopharm progresses in their stand against drug-resistant N. gonorrhoeae with extended CARB-X funding of their Debio 1453 antibiotic program

Read more
October 9, 2019

A pancreatic and colorectal cancer trial initiated to address the needs of patients with Immune Checkpoint Inhibitor (ICI)-resistant disease by…

Read more
September 30, 2019

Debiopharm’s novel IAP antagonist Debio 1143 achieves outstanding Phase II results for high-risk Head and Neck cancer patients

Read more
September 30, 2019

The Japanese Cancer Association and Debiopharm Announce Winners of the 2019 JCA-Mauvernay Award

Read more
September 3, 2019

Debiopharm successfully completes randomized Phase II study for IAP antagonist Debio 1143 in high risk head & neck cancer patients

Read more
July 9, 2019

Debiopharm and BIOASTER join forces to expand research to combat infectious diseases

Read more
June 12, 2019

Debiopharm and Ipsen extend their strategic Decapeptyl® (triptorelin) partnership for another 15 years

Read more
June 3, 2019

Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel…

Read more
May 29, 2019

Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Read more